Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECORD 2 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE, Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Hip Replacement.

NCT00332020 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00332020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00332020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECORD 2 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE, Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Hip Replacement.
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
June 30, 2007
Enrollment
2,457 (actual)
Sites
126

Conditions

As the registry lists them; a condition with its own page is linked.

prevention, venous thromboembolism